1fvk Citations

Structural analysis of three His32 mutants of DsbA: support for an electrostatic role of His32 in DsbA stability.

Protein Sci 6 1893-900 (1997)
Related entries: 1ac1, 1acv, 1fvj

Cited: 80 times
EuropePMC logo PMID: 9300489

Abstract

DsbA, a 21-kDa protein from Escherichia coli, is a potent oxidizing disulfide catalyst required for disulfide bond formation in secreted proteins. The active site of DsbA is similar to that of mammalian protein disulfide isomerases, and includes a reversible disulfide bond formed from cysteines separated by two residues (Cys30-Pro31-His32-Cys33). Unlike most protein disulfides, the active-site disulfide of DsbA is highly reactive and the oxidized form of DsbA is much less stable than the reduced form at physiological pH. His32, one of the two residues between the active-site cysteines, is critical to the oxidizing power of DsbA and to the relative instability of the protein in the oxidized form. Mutation of this single residue to tyrosine, serine, or leucine results in a significant increase in stability (of approximately 5-7 kcal/mol) of the oxidized His32 variants relative to the oxidized wild-type protein. Despite the dramatic changes in stability, the structures of all three oxidized DsbA His32 variants are very similar to the wild-type oxidized structure, including conservation of solvent atoms near the active-site residue, Cys30. These results show that the His32 residue does not exert a conformational effect on the structure of DsbA. The destabilizing effect of His32 on oxidized DsbA is therefore most likely electrostatic in nature.

Reviews - 1fvk mentioned but not cited (5)

  1. Mechanisms of oxidative protein folding in the bacterial cell envelope. Kadokura H, Beckwith J. Antioxid Redox Signal 13 1231-1246 (2010)
  2. Targeting Bacterial Dsb Proteins for the Development of Anti-Virulence Agents. Smith RP, Paxman JJ, Scanlon MJ, Heras B. Molecules 21 E811 (2016)
  3. Topological variation in the evolution of new reactions in functionally diverse enzyme superfamilies. Meng EC, Babbitt PC. Curr Opin Struct Biol 21 391-397 (2011)
  4. Periplasmic Targets for the Development of Effective Antimicrobials against Gram-Negative Bacteria. Pandeya A, Ojo I, Alegun O, Wei Y. ACS Infect Dis 6 2337-2354 (2020)
  5. Structural bioinformatic analysis of DsbA proteins and their pathogenicity associated substrates. Santos-Martin C, Wang G, Subedi P, Hor L, Totsika M, Paxman JJ, Heras B. Comput Struct Biotechnol J 19 4725-4737 (2021)

Articles - 1fvk mentioned but not cited (26)



Reviews citing this publication (9)

  1. IgG4 breaking the rules. Aalberse RC, Schuurman J. Immunology 105 9-19 (2002)
  2. Understanding the pK(a) of redox cysteines: the key role of hydrogen bonding. Roos G, Foloppe N, Messens J. Antioxid Redox Signal 18 94-127 (2013)
  3. Catalysis of disulfide bond formation and isomerization in the Escherichia coli periplasm. Nakamoto H, Bardwell JC. Biochim Biophys Acta 1694 111-119 (2004)
  4. Disulfide-linked protein folding pathways. Mamathambika BS, Bardwell JC. Annu Rev Cell Dev Biol 24 211-235 (2008)
  5. Structure and function of DsbA, a key bacterial oxidative folding catalyst. Shouldice SR, Heras B, Walden PM, Totsika M, Schembri MA, Martin JL. Antioxid Redox Signal 14 1729-1760 (2011)
  6. Disulfide-Bond-Forming Pathways in Gram-Positive Bacteria. Reardon-Robinson ME, Ton-That H. J Bacteriol 198 746-754 (2015)
  7. Four structural subclasses of the antivirulence drug target disulfide oxidoreductase DsbA provide a platform for design of subclass-specific inhibitors. McMahon RM, Premkumar L, Martin JL. Biochim Biophys Acta 1844 1391-1401 (2014)
  8. Key players involved in bacterial disulfide-bond formation. Tan JT, Bardwell JC. Chembiochem 5 1479-1487 (2004)
  9. Structural Analyses of the Multicopper Site of CopG Support a Role as a Redox Enzyme. Hausrath AC, McEvoy MM. Adv Exp Med Biol 1414 97-121 (2023)

Articles citing this publication (40)



Related citations provided by authors (2)